Market Context: 2022 in Focus
In a year when the S&P 500 plunged and investors faced a textbook bear-market environment, some corners of the market offered a measure of shelter. Among them, the Vanguard Health Care ETF, which tracks a broad mix of health-care stocks, stood out for its resilience.
Data shows that the health-care fund declined modestly in 2022, even as the S&P 500 dropped around 18%. The episode underscores a simple, persistent truth: defensive sectors can cushion losses when the broader market sprints lower. When 2022 tore through the tape, this contrast became particularly pronounced across retirement portfolios.
For context, health-care equities were not immune to the year’s rates surge and inflation pressure, but the magnitude of the downside was notably smaller. The fund’s exposure to dozens of pharmaceutical firms, hospitals, biotech developers, and medical equipment makers helped it dodge the worst of the selling pressure that swept cyclicals and technology names.
Why Healthcare Proved Defensive in a Selloff
Defensive sectors—like health care, consumer staples, and utilities—tend to hold up when confidence slips. In health care, people still need medicines, hospital visits, and medical devices even as markets wobble. Analysts say the sector benefits from predictable cash flows and durable demand, which translates into steadier earnings and a lower beta in many periods of market stress.
- Health care represented a relatively low‑volatility sleeve during a tumultuous 2022.
- VHT counts more than 400 health-care names, offering breadth and diversification at a low cost.
- Expense ratios for these exchange‑traded funds hover around sub‑0.1%, providing cost‑efficient exposure to a defensive theme.
“During downturns, the sector's earnings visibility matters more than growth prospects,” said a portfolio strategist at a leading brokerage. “The inelastic demand for medical care translates into more stable revenue than many cyclicals.”
Retirement Accounts and Allocation Gaps
Despite the defensiveness of health care, many retirement accounts remain underweight the sector. Plan sponsors often favor broad market indexes and bond‑like holdings, citing diversification needs, liquidity considerations, and fiduciary guidelines. The result: even a defensive tilt can be muted inside a 401(k) lineup.
VHT offers exposure to more than 400 health-care firms with a cost of roughly 0.09% to 0.10% annually. It is widely accessible in brokerage accounts and some retirement plans, but it does not appear on every 401(k) menu. The mismatch matters because older investors have often accumulated more wealth inside these plans and face a constraint when choosing sector bets inside those accounts.
Comparative Performance: 2022 Snapshot
To illustrate the divergence, consider a calendar view: the S&P 500’s decline overshadowed stock-market breadth in 2022, while health care equities outperformed relative to the overall market. A representative comparison shows the health-care ETF sinking at a much slower pace than the broader index, a pattern that attracted interest from retiree planners looking to reduce drawdowns without abandoning equity exposure.
From a cost perspective, the fund’s sub‑0.1% expense ratio is attractive for long‑horizon investing. In retirement planning, where every basis point matters across decades, cheaper access to a defensive theme can compound benefits over time.
Current Market Context: Why This Matters Today
As of mid‑2026, investors face a different backdrop: inflation has moderated in many regions, but bond yields remain elevated relative to pre‑2022 levels. The rotation toward quality names and cash‑flow stability has rekindled interest in defensive exposures, including health care ETFs, as a ballast against potential pullbacks in growth stocks.
The core question for retirement portfolios is whether the inclusion of health care exposure should be treated as core or satellite. Plan design, fund availability, and individual risk tolerance all play a part in making that determination. The broader trend suggests a renewed openness to defensives among those who want a smoother glide path toward income in retirement.
Practical Guidance for Investors
- Consider a dedicated health-care sleeve as a complement to core broad-market holdings, not a replacement for core stock exposure.
- Weigh cost versus diversification: VHT’s low expense ratio makes it a compelling option for taxable, retirement, and rollover accounts alike.
- Assess plan flexibility: If your 401(k) lacks health-care options, explore an IRA or taxable account to capture the same defensive attributes.
- Monitor the macro backdrop: healthcare demand remains relatively inelastic, but policy changes and reimbursement dynamics can influence earnings trajectories over time.
Investor Takeaways
Defensive exposure can reduce portfolio volatility during downturns, but it does not guarantee positive performance in every environment. Cost efficiency and diversification matter just as much as the allocation itself, especially for long‑horizon investors relying on retirement income.
Plan sponsors and individual investors should weigh the benefits of a health-care sleeve against the constraints of their accounts. The health-care ETF landscape offers a range of options that can be tailored to risk tolerance, income needs, and tax considerations.
Bottom Line: The Tale of When 2022 Tore Through
The year when 2022 tore through the market delivered a clear lesson: defensive sectors can cushion losses when risk assets retreat. For retirees and those nearing retirement, the episode underscores the importance of portfolio design—balancing stability with growth potential. A thoughtful mix that includes a health-care ETF, alongside traditional broad-market and fixed-income holdings, can help smooth the ride without sacrificing long‑term income goals.
As market conditions evolve, the question to keep asking is how to balance the need for security with the pursuit of returns. When 2022 tore through, the answer wasn’t to abandon equities, but to adjust allocations so the defense has a seat at the table for the journey ahead.
Discussion